James H. Derrington

Array ( [id] => 12661204 [patent_doc_number] => 20180112234 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2018-04-26 [patent_title] => METHODS AND COMPOSITIONS FOR GENE EDITING [patent_app_type] => utility [patent_app_number] => 15/457866 [patent_app_country] => US [patent_app_date] => 2017-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18259 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11866480 [patent_doc_number] => 20170233765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'NON-DISRUPTIVE GENE TARGETING' [patent_app_type] => utility [patent_app_number] => 15/457923 [patent_app_country] => US [patent_app_date] => 2017-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 28262 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12661204 [patent_doc_number] => 20180112234 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2018-04-26 [patent_title] => METHODS AND COMPOSITIONS FOR GENE EDITING [patent_app_type] => utility [patent_app_number] => 15/457866 [patent_app_country] => US [patent_app_date] => 2017-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18259 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11977613 [patent_doc_number] => 20170281768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'NOVEL NUCLEIC ACID MOLECULES WITH ANTITUMORAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 15/454769 [patent_app_country] => US [patent_app_date] => 2017-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 21594 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15454769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15228087 [patent_doc_number] => 10501757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof [patent_app_type] => utility [patent_app_number] => 15/449076 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22292 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11704686 [patent_doc_number] => 20170173185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'GLOBIN GENE THERAPY FOR TREATING HEMOGLOBINOPATHIES' [patent_app_type] => utility [patent_app_number] => 15/449416 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 37029 [patent_no_of_claims] => 110 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15160821 [patent_doc_number] => 10485883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor [patent_app_type] => utility [patent_app_number] => 15/433322 [patent_app_country] => US [patent_app_date] => 2017-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 125 [patent_figures_cnt] => 128 [patent_no_of_words] => 23663 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15433322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13703245 [patent_doc_number] => 20170362577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => RECOMBINANT AAV PRODUCTION IN MAMMALIAN CELLS [patent_app_type] => utility [patent_app_number] => 15/424014 [patent_app_country] => US [patent_app_date] => 2017-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15424014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16539345 [patent_doc_number] => 20200405758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => A CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO B-CELL MATURATION ANTIGEN, A RECOMBINANT EXPRESSION VECTOR AND A METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 16/073575 [patent_app_country] => US [patent_app_date] => 2017-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8969 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14482751 [patent_doc_number] => 10328136 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-25 [patent_title] => Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors [patent_app_type] => utility [patent_app_number] => 15/409245 [patent_app_country] => US [patent_app_date] => 2017-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 15111 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11756064 [patent_doc_number] => 20170202931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE' [patent_app_type] => utility [patent_app_number] => 15/404890 [patent_app_country] => US [patent_app_date] => 2017-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 33313 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15404890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11851991 [patent_doc_number] => 20170226483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'Methods and Vectors to Produce Vector Free Induced Pluripotent Stem Cells' [patent_app_type] => utility [patent_app_number] => 15/404960 [patent_app_country] => US [patent_app_date] => 2017-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21285 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 55 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15404960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13690021 [patent_doc_number] => 20170355965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-14 [patent_title] => NON-VIRAL IPSCS INDUCING METHOD, COMPOSITIONS, KITS AND IPSCS [patent_app_type] => utility [patent_app_number] => 15/393288 [patent_app_country] => US [patent_app_date] => 2016-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15393288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17938639 [patent_doc_number] => 11473083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-18 [patent_title] => Compositions and methods for decreasing tau expression [patent_app_type] => utility [patent_app_number] => 15/383452 [patent_app_country] => US [patent_app_date] => 2016-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 21370 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19884356 [patent_doc_number] => 12270050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-08 [patent_title] => Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and using [patent_app_type] => utility [patent_app_number] => 16/060651 [patent_app_country] => US [patent_app_date] => 2016-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 77 [patent_no_of_words] => 19553 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11514586 [patent_doc_number] => 20170081658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-23 [patent_title] => 'Rapid Affinity Measurement of Peptide Ligands and Reagents Therefor' [patent_app_type] => utility [patent_app_number] => 15/367255 [patent_app_country] => US [patent_app_date] => 2016-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13799 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11499195 [patent_doc_number] => 20170073380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-16 [patent_title] => 'HIGH-EFFICIENCY, SODIUM-SPECIFIC, BLUE-SHIFTED CHANNELRHODOPSINS' [patent_app_type] => utility [patent_app_number] => 15/365189 [patent_app_country] => US [patent_app_date] => 2016-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 34276 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15365189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11491500 [patent_doc_number] => 20170065685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/357964 [patent_app_country] => US [patent_app_date] => 2016-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21784 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15357964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15008915 [patent_doc_number] => 10450574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-22 [patent_title] => Transient transfection method for retroviral production [patent_app_type] => utility [patent_app_number] => 15/356813 [patent_app_country] => US [patent_app_date] => 2016-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9453 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15356813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16909144 [patent_doc_number] => 11041173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-22 [patent_title] => Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications [patent_app_type] => utility [patent_app_number] => 15/349603 [patent_app_country] => US [patent_app_date] => 2016-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 109 [patent_figures_cnt] => 162 [patent_no_of_words] => 110782 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349603 [rel_patent_id] =>[rel_patent_doc_number] =>)